Rafagen is an early commercialization stage biotech company with a patented core gene technology having two different areas of application: 1. Biotherapeutics (protein/antibody drugs) manufacturing for a dramatic increase in drug production yield. 2. Gene/Cell-based drug development for a significant increase in drug safety by minimizing toxic effects of the drug.